Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools

Lipids

Volumn 47, Issue 10, 2012, Pages 941-950

  Neuschwander Tetri, Brent A ^a,b   Ford, David A ^a,b   Acharya, Sahaja ^a   Gilkey, George ^a   Basaranoglu, Metin ^a   Tetri, Laura H ^a   Brunt, Elizabeth M ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Fatty liver; High fructose corn syrup; Leptin; Obesity; Resistin

Indexed keywords

CHOLESTEROL ESTER; TRANS FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT INTAKE; LIPID ANALYSIS; LIPID DIET; LIPID LIVER LEVEL; LIVER HISTOLOGY; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; WEIGHT REDUCTION;

ANIMALS; CHOLESTEROL ESTERS; DIETARY FATS; FATTY LIVER; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; TRANS FATTY ACIDS;

MUS; ZEA MAYS;

EID: 84866736015     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3709-7     Document Type: Article

References (48)

1. Bugianesi E, Marzocchi R, Villanova N, Marchesini G (2004) Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Baillieres Best Pract Res Clin Gastroenterol 18:1105-1116
2. Neuschwander-Tetri BA (2009) Lifestyle modification as the primary treatment of NASH. Clin Liver Dis 13:649-665
3. Haynes P, Liangpunsakul S, Chalasani N (2004) Nonalcoholic fatty liver disease in individuals with severe obesity. Clin Liver Dis 8:535-547
4. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris HT, Caro JF (1990) Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85:1349-1355
5. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K (1997) Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27:103-107
6. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603-608
7. Harrison SA, Day CP (2007) Benefits of lifestyle modification in NAFLD. Gut 56:1760-1769
8. Schäfer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F, Machicao F, Häring HU, Fritsche A, Stefan N (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 37:535-543
9. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA (2008) Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 295:G987- G995
10. Obara N, Fukushima K, Ueno Y, Wakui Y, Kimura O, Tamai K, Kakazu E, Inoue J, Kondo Y, Ogawa N, Sato K, Tsuduki T, Ishida K, Shimosegawa T (2010) Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J Hepatol 53:326-334
11. Machado RM, Stefano JT, Oliveira CP, Mello ES, Ferreira FD, Nunes VS, de Lima VM, Quintão EC, Catanozi S, Nakandakare ER, Lottenberg AM (2010) Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr 140:1127-1132
12. Koppe SW, Elias M, Moseley RH, Green RM (2009) trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 297:G378- G384
13. Kraft J, Spiltoir JI, Salter AM, Lock AL (2011) Differential effects of the trans-18:1 isomer profile of partially hydrogenated vegetable oils on cholesterol and lipoprotein metabolism in male F1B hamsters. J Nutr 141:1819-1826
14. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
15. Ford DA, Gross RW (1988) Identification of endogenous 1-O-alk-1'-enyl-2-acyl-sn-glycerol in myocardium and its effective utilization by choline phosphotransferase. J Biol Chem 263:2644-2650
16. Shirasawa S, Sasaki A, Saida Y, Satoh C (2007) A rapid method for trans-fatty acid determination using a single capillary GC. J Oleo Sci 56:53-58
17. Zambonin L, Ferreri C, Cabrini L, Prata C, Chatgilialoglu C, Landi L (2006) Occurrence of trans fatty acids in rats fed a trans-free diet: a free radical-mediated formation? Free Radic Biol Med 40:1549-1556
18. Bouneva I, Kirby DF (2004) Management of nonalcoholic fatty liver disease: weight control. Clin Liver Dis 8:693-713
19. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin P-H, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ, Premier Collaborative Research Group (2006) Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 144:485-495
20. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360:859-873
21. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA (2009) Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 49: 80-86
22. Ahima RS (2007) Insulin resistance: cause or consequence of nonalcoholic steatohepatitis? Gastroenterology 132:444-446
23. Hill JO, Lin D, Yakubu F, Peters JC (1992) Development of dietary obesity in rats, influence of amount and composition of dietary fat. Int J Obes Relat Metab Disord 16:321-333
24. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW (2006) Central nervous system control of food intake and body weight. Nature 443:289-295
25. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93-100
26. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ (2008) Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 295:R1370-R1375
27. Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, Al-Johi M, Al-Rabiah R, Zaidi MZ, Al-Mohanna FA (2009) Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 50: 1521-1537
28. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ (2010) High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52:934-944
29. Neuschwander-Tetri BA (2011) No transfats. Hepatology 54:750-751
30. Kechagias S, Ernersson Å, Dahlqvist O, Lundberg P, Lindström T, Nystrom FH, for the Fast Food Study Group (2008) Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 57:649-654
31. Beare-Rogers JL (1970) The deposition of polyunsaturated fatty acids in the rat fed partially hydrogenated vegetable oil. J Am Oil Chem Soc 47:487-489
32. Guzmán M, Klein W, Gómez del Pulgar T, Geelen MJ (1999) Metabolism of trans fatty acids by hepatocytes. Lipids 34:381-386
33. Lawson LD, Holman RT (1981) β-Oxidation of the geometric and positional isomers of octadecenoic acid by rat heart and liver mitochondria. Biochim Biophys Acta 665:60-65
34. Lawson LD, Kummerow FA (1979) β-Oxidation of the coenzyme A esters of elaidic, oleic, and stearic acids and their full-cycle intermediates by rat heart mitochondria. Biochim Biophys Acta 573:245-254
35. Lawson LD, Kummerow FA (1979) β-Oxidation of the coenzyme A esters of vaccenic, elaidic, and petroselaidic acids by rat heart mitochondria. Lipids 14:501-503
36. Ide T, Watanabe M, Sugano M, Yamamoto I (1987) Activities of liver mitochondrial and peroxisomal fatty acid oxidation enzymes in rats fed trans fat. Lipids 22:6-10
37. Wood R, Chumbler F, Wiegand R (1977) Incorporation of dietary cis and trans isomers of octadecenoate in lipid classes of liver and hepatoma. J Biol Chem 252:1965-1970
38. Moore CE, Alfin-Slater RB, Aftergood L (1980) Incorporation and disappearance of trans fatty acids in rat tissues. Am J Clin Nutr 33:2318-2323
39. Roach C, Feller SE, Ward JA, Shaikh SR, Zerouga M, Stillwell W (2004) Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry 43:6344-6351
40. Niu SL, Mitchell DC, Litman BJ (2005) trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 44:4458-4465
41. Ibrahim A, Natrajan S, Ghafoorunissa R (2005) Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism 54:240-246
42. Hirsch J, Farquhar JW, Ahrens EH Jr, Peterson ML, Stoffel W (1960) Studies of adipose tissue in man. A microtechnic for sampling and analysis. Am J Clin Nutr 8:499-511
43. Flowers MT (2009) The Δ9 fatty acid desaturation index as a predictor of metabolic disease. Clin Chem 55:2071-2073
44. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM (2002) Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43:1899-1907
45. Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, Hoffman EP, Thyfault JP, Stevens R, Dohm GL, Houmard JA, Muoio DM (2005) Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2:251-261
46. Li ZZ, Berk M, McIntyre TM, Feldstein AE (2009) Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 284:5637-5644
47. Neuschwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52:774-788
48. Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring HU, Schleicher E (2009) Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem 55:2113-2120